The latest price target for Envoy Medical (NASDAQ:COCH) was reported by Brookline Capital on October 14, 2024. The analyst firm set a price target for $9.00 expecting COCH to rise to within 12 months (a possible 345.54% upside). 6 analyst firms have reported ratings in the last year.

The latest analyst rating for Envoy Medical (NASDAQ:COCH) was provided by Brookline Capital, and Envoy Medical initiated their buy rating.

There is no last upgrade for Envoy Medical

There is no last downgrade for Envoy Medical.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Envoy Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Envoy Medical was filed on October 14, 2024 so you should expect the next rating to be made available sometime around October 14, 2025.

While ratings are subjective and will change, the latest Envoy Medical (COCH) rating was a initiated with a price target of $0.00 to $9.00. The current price Envoy Medical (COCH) is trading at is $2.02, which is within the analyst’s predicted range.